YCBD|cbdMD Inc|Price:0.923|Chg%:-0.04

More Details of cbdMD Inc Company

cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.

cbdMD Inc Info



Ticker SymbolYCBD

Company namecbdMD Inc

IPO dateNov 17, 2017

CEOKennedy (T. Ronan)

Number of employees42

Security typeOrdinary Share

Fiscal year-endNov 17

Address8845 Red Oak Blvd

CityCHARLOTTE

Stock exchangeNASDAQ OMX – NASDAQ Basic Amex

CountryUnited States of America

Postal code28217-5593

Phone17044453060

Websitehttps://www.cbdmd.com/

Ticker SymbolYCBD

IPO dateNov 17, 2017

CEOKennedy (T. Ronan)

Company Executives of cbdMD Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Scott G. Stephen

Independent Chairman of the Board

1.83K

-393.00%

Mr. Bakari T. Sellers

Independent Director

1.75K

-373.00%

Mr. William F. Raines, III

Independent Director

--

Mr. T. Ronan Kennedy

Chief Executive Officer, Chief Financial Officer, Director

--

Dr. Sibyl Swift

Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director

--

Mr. Bradley Whitford

Chief Accounting Officer, Treasurer, Company Secretary

--

Name

Name/Position

Position

Shareholding

Change

Mr. Scott G. Stephen

Independent Chairman of the Board

1.83K

-393.00%

Mr. Bakari T. Sellers

Independent Director

1.75K

-373.00%

Mr. William F. Raines, III

Independent Director

--

Mr. T. Ronan Kennedy

Chief Executive Officer, Chief Financial Officer, Director

--

Dr. Sibyl Swift

Chief Science Officer, Vice President - Scientific and Regulatory Affairs, Director

--

Mr. Bradley Whitford

Chief Accounting Officer, Treasurer, Company Secretary

--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

By BusinessUSD

Name

Revenue

Proportion

E-commerce sales

14.72M

76.68%

Wholesale sales

4.48M

23.32%

Relevant data have not been disclosed by the company yet.

By Business

By Region

By BusinessUSD

Name

Revenue

Proportion

E-commerce sales

14.72M

76.68%

Wholesale sales

4.48M

23.32%

Shareholding Stats

Updated: Mon, Feb 2

Shareholders

Shareholder Types

Shareholders

Proportion

Porter (Jeffrey H)

5.48%

Crc Investment Fund LP

4.16%

CSS, LLC

1.36%

The Vanguard Group, Inc.

0.94%

Chapin Davis Asset Management

0.77%

Other

87.30%

Shareholders

Proportion

Porter (Jeffrey H)

5.48%

Crc Investment Fund LP

4.16%

CSS, LLC

1.36%

The Vanguard Group, Inc.

0.94%

Chapin Davis Asset Management

0.77%

Other

87.30%

Shareholder Types

Shareholders

Proportion

Individual Investor

6.43%

Investment Advisor

4.22%

Corporation

4.16%

Investment Advisor/Hedge Fund

0.13%

Other

85.06%

Institutional Shareholding



Updated: Wed, Jan 21

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q4

33

436.16K

5.38%

--

2025Q4

53

457.02K

4.35%

-122.38K

2025Q3

51

502.25K

5.64%

+188.29K

2025Q2

61

1.71M

19.14%

+1.55M

2025Q1

80

154.62K

3.22%

-19.13K

2024Q4

76

811.68K

23.02%

+42.15K

2024Q3

80

869.63K

30.51%

+134.84K

2024Q2

85

734.40K

27.03%

-50.91K

2024Q1

91

757.62K

28.39%

-18.50K

2023Q4

95

764.16K

29.72%

+83.63K

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Porter (Jeffrey H)

73.26K

0.78%

+73.26K

--

May 16, 2025

Crc Investment Fund LP

436.15K

4.63%

-797.41K

-64.64%

Dec 17, 2025

CSS, LLC

142.62K

1.51%

--

Sep 30, 2025

The Vanguard Group, Inc.

51.56K

0.55%

+51.56K

--

Sep 30, 2025

Chapin Davis Asset Management

121.55K

1.29%

+2.92K

+2.47%

Sep 30, 2025

Kennedy (Thomas Ronan)

454.31K

4.82%

+445.00K

+4778.27%

Nov 28, 2025

Alesco Advisors LLC

68.51K

0.73%

--

Sep 30, 2025

Roe (Kevin Charles)

4.52K

0.05%

+4.52K

--

May 16, 2025

Commonwealth Financial Network

16.25K

0.17%

--

Sep 30, 2025

Scientech Research LLC

15.41K

0.16%

+15.41K

--

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

Cambria Cannabis ETF

0%

iShares Core S&P Total U.S. Stock Market ETF

0%

Amplify Seymour Cannabis ETF

0%

Cambria Cannabis ETF

Proportion0%

iShares Core S&P Total U.S. Stock Market ETF

Proportion0%

Amplify Seymour Cannabis ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

Apr 21, 2025

Merger

8→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Date

Ex-dividend Date

Type

Ratio

Apr 21, 2025

Merger

8→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1

Apr 14, 2023

Merger

45→1